Haleon (LON:HLN) Shares Down 1.9% – Should You Sell?

Haleon plc (LON:HLNGet Free Report)’s share price dropped 1.9% during trading on Monday . The stock traded as low as GBX 382.60 ($4.94) and last traded at GBX 385.50 ($4.98). Approximately 14,722,720 shares traded hands during mid-day trading, a decline of 48% from the average daily volume of 28,321,533 shares. The stock had previously closed at GBX 393.15 ($5.08).

Analyst Upgrades and Downgrades

Separately, Berenberg Bank increased their price target on Haleon from GBX 456 ($5.89) to GBX 457 ($5.91) and gave the stock a “buy” rating in a report on Friday, February 28th.

Check Out Our Latest Analysis on HLN

Haleon Stock Performance

The company has a current ratio of 0.84, a quick ratio of 0.93 and a debt-to-equity ratio of 53.36. The stock has a market capitalization of £34.79 billion, a price-to-earnings ratio of 32.42, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. The firm’s fifty day moving average price is GBX 385.76 and its 200 day moving average price is GBX 381.76.

Haleon (LON:HLNGet Free Report) last released its quarterly earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.20) EPS for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. Analysts forecast that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Haleon Increases Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be paid a GBX 4.60 ($0.06) dividend. This is a positive change from Haleon’s previous dividend of $2.00. The ex-dividend date of this dividend is Thursday, April 24th. This represents a dividend yield of 1.18%. Haleon’s dividend payout ratio (DPR) is presently 50.46%.

About Haleon

(Get Free Report)

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.

Recommended Stories

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.